THE ROLE OF AFRICAN UNIVERSITIES AND RESEARCH INSTITUTIONS IN ADVANCING SICKLE CELL DISEASE INNOVATION: A PERSPECTIVE

Emmanuel Ifeanyi Obeagu; Priya Homa Chukwu

doi:10.22270/ujpr.v11i1.1493

Emmanuel Ifeanyi Obeagu Division of Haematology, Department of Biomedical and Laboratory Science, Africa University, Zimbabwe. Department of Molecular Medicine and Haematology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Priya Homa Chukwu Department of Haematology and Blood Transfusion Science, Rivers State University, Port Harcourt, Rivers State, Nigeria.

10.22270/ujpr.v11i1.1493

Keywords:

African Universities, genetic disorders, public health, research innovation, sickle cell disease

Abstract

Sickle Cell Disease (SCD) remains one of the most prevalent genetic disorders in Africa, contributing significantly to morbidity and mortality across the continent. African universities and research institutions have emerged as key players in advancing innovation to combat this burden through focused research, capacity building, and policy advocacy. Their localized efforts are essential in addressing the unique genetic, environmental, and socio-economic factors influencing SCD in African populations. These institutions have made substantial contributions in understanding the molecular genetics of SCD, conducting epidemiological studies, and leading clinical trials tailored to local contexts. Additionally, they play a crucial role in training healthcare professionals and researchers, thereby strengthening the continent’s capacity to provide effective care and develop novel therapeutic approaches. Collaborative research networks and dedicated centers further accelerate innovation, facilitating the translation of scientific discoveries into practical interventions such as newborn screening and point-of-care diagnostics.